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Abstract
Background: Monitoring the incidence of bacterial meningitis is important to plan and evaluate
preventive polices. The study's aim was to estimate the incidence of bacterial meningitis by
aetiological agent in the period 2001–2005, in Lazio Italy (5.3 mln inhabitants).
Methods:  Data collected from four sources – hospital surveillance of bacterial meningitis,
laboratory information system, the mandatory infectious diseases notifications, and hospital
information system – were combined into a single archive.
Results: 944 cases were reported, 89% were classified as community acquired. S. pneumoniae was
the most frequent aetiological agent in Lazio, followed by N. meningitis. Incidence of H. influenzae
decreased during the period. 17% of the cases had an unknown aetiology and 13% unspecified
bacteria. The overall incidence was 3.7/100,000. Children under 1 year were most affected (50.3/
100.000), followed by 1–4 year olds (12.5/100,000). The percentage of meningitis due to
aetiological agents included in the vaccine targets, not considering age, is 31%. Streptococcus spp.
was the primary cause of meningitis in the first three months of life. The capture-recapture model
estimated underreporting at 17.2% of the overall incidence.
Conclusion: Vaccine policies should be planned and monitored based on these results. The
integrated surveillance system allowed us to observe a drop in H. influenzae b meningitis incidence
consequent to the implementation of a mass vaccination of newborns.
Background
Bacterial meningitis, of all infectious diseases, is one of
the most relevant for public health professionals and deci-
sion makers [1]. There are three main reasons for its rele-
vance: 1) it is a serious disease with a high fatality rate (up
to 20%) [2,3] and sequalae [4], although rare, (3.5/
100,000) [5] are present and visible in the general popu-
lation; 2) it affects young children in particular; 3) there
are three vaccines against the most common aetiological
agents, Haemophilus influenzae b, Streptococcus pneumoniae,
and Neisseria meningititis.
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To plan a mass vaccination we need to quantify the por-
tion of the disease that is preventable by vaccination. The
information essential for this task is: to identify the cases,
to ascertain the aetiology, and to determine if the infec-
tion was actually preventable in that patient. Routine sur-
veillance systems, based on notifications of the infectious
disease, need to be timely to activate prophylactic control
measures and often are not accurate in terms of aetiology,
furthermore, they are intrinsically affected by under-
reporting [6].
In other words, a sensitive, specific and accurate surveil-
lance system is necessary to plan an efficient mass vaccina-
tion.
The solution adopted in several countries has been to
enhance notification systems by integrating them with the
information collected by different sources, some very sen-
sitive, such as the hospital database, and others very spe-
cific, such as laboratory isolates.
A surveillance system that integrates three data sources
was implemented in our region in 1997; the initial results
of that system have already been described [7,8]. A new
source of information, the laboratory information system,
was added to it in 1999. The advantages of this integrated
surveillance are that we can follow the history of case hos-
pitalizations, including emergency department visits,
before and after disease onset, to investigate pre-existing
medical conditions and health care outcomes.
This paper summarises the results of 5 years (2001–2005)
of bacterial meningitis surveillance in Lazio. We present
the incidence of meningitis by aetiological agent (by sin-
gle bacteria and by vaccine-targeted vaccine targeted bac-
teria), patient characteristics (age, gender, and place of
birth), and by origin of infection (community acquired,
hospital and in HIV/AIDS).
Methods
Population
Lazio has 5.3 million inhabitants and includes the metro-
politan area of Rome (2.9 million); the number of live
births per year is about 49.000. We included cases that
occurred between 2001 and 2005.
Sources
Individual data from four different data sources were
linked to produce a single database, eliminating redun-
dant records and discrepancies. The following sources of
data were analysed:
The mandatory Infectious disease notification System (NDS)
The NDS collects reports of acute infectious diseases
according to a national law that requires case notification
to the Local Health Unit [9]. The notification reports
include: personal data of the patients; diagnosis; symp-
toms onset date; risk factors; and, eventually, exitus.
Meningococcal diseases (meningitis and sepsis) have to
be reported within 12 hours to begin prophylactic meas-
ures; meningitis due to other bacteria has to be reported
within two days. Notifications are updated after the case is
confirmed clinically, and when the outcome of the disease
is death.
Hospital Surveillance of Bacterial Meningitis
The hospital surveillance system (HSS) of bacterial men-
ingitis [10], in operation since 1994, is a voluntary, par-
tially laboratory-based surveillance system that collects
reports of bacterial meningitis from hospitals. Cases are
reported to the Agency for Public Health by the medical
staff of the hospital health management.
Laboratory based surveillance of invasive bacterial diseases
The Laboratory Information System (LIS), which started
in 1996 following the enactment of a regional regulation,
collects all positive bacterial samples from normally ster-
ile sites [11]. Furthermore, all strains of Haemophilus influ-
enzae, Neisseria meningitidis and Streptococcus pneumoniae
must be sent to the central laboratory of the region for
serotyping and storage.
Hospital Information System
The Hospital Information System (HIS) of the Lazio
region has been active since 1995 [7,12]: it routinely col-
lects discharge abstract data from all Lazio public and pri-
vate hospitals (more than 150 facilities) and includes:
admission and discharge dates, discharge status, up to six
discharge diagnoses (ICD-9-CM), and up to six hospital
procedures (ICD-9-CM).
In addition, we used the Emergency Information System
(EIS) to identify the reason for the first admission, in
order to determine which were probable hospital infec-
tions (see classification of cases). EIS collects records of all
emergency room visits in Lazio [13]. It includes all 60 EDs
(Emergency Departments) from the region. It reports: the
name, date and place of birth of the patient, up to four
diagnoses coded according to ICD-9-CM, and the princi-
pal reason for the admission. Data from this source were
used.
The information about disease outcome was obtained
from the HIS (i.e. in-hospital mortality) and NDS (short
term follow-up).
Case selection
We adopted the following inclusion criteria for the four
sources:BMC Infectious Diseases 2009, 9:13 http://www.biomedcentral.com/1471-2334/9/13
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▪ NDS: all meningitis cases reported with symptom onset
in the years 2001–2005;
▪ HSS: all cases reported with symptom onset in the years
2001–2005;
▪ LIS: all positive cerebro-spinal fluid samples with date of
diagnosis in the years 2001–2005, for Neisseria meningitis
we also included blood isolates;
▪ HIS: all hospitalisations reporting a meningitis diagnos-
tic code as principal or secondary diagnoses with admis-
sion in the years 2001–2005 (ICD-9-CM codes: 036.0–2,
036.9, 013, 320.0, 320.1, 320.2, 320.3, 320.7, 320.8,
320.9, 003.21). Multiple hospitalizations due to transfers
were combined; admissions for transferred patients were
followed until discharge or death.
We classified as foreign cases all the cases occurring in for-
eigners. When residence was not given, we used place of
birth.
Record Linkage
The cases reported from each source were combined to
obtain a list of single episodes of meningitis. Linkage keys
were name, family name and date of birth for the NDS,
LIS and HIS; for the HSS we used age instead of date of
birth.
Repeated episodes with the same aetiological agent or
compatible aetiological diagnosis (i.e. "non specified"/
"specified" and "non specified"/"non specified") were
considered as a single episode when they occurred within
30 days of the previous hospital discharge or within 40
days of the onset of symptoms for not-hospitalised cases
(30 days + 10 days is the median length of stay for hospi-
talised cases); otherwise, they were considered as distinct
episodes. We checked the clinical records for patients with
more than one episode in the study period to ascertain
that the second was truly a new episode.
Origin of the infection
The identified cases of meningitis were classified into
three categories according to the origin of infection: prob-
able hospital infection, AIDS/HIV, or community
acquired infections. The following criteria were used:
Probable hospital infection
the presence of at least one of the following conditions: 1)
principal diagnosis other than meningitis or other infec-
tious diseases that could degenerate into meningitis (see
appendix); a hospitalisation within 10 days before the
onset of symptoms, without a diagnosis of an infectious
disease, with a length of stay of more than 24 h; 2) pri-
mary or secondary diagnosis of trauma (ICD-9-CM codes
800–959.9) or shunt of the cerebro-spinal fluid (ICD-9-
CM codes 996.2, 996.63, 996.75, 997.0, V45.2); 3) diag-
nosis of trauma or pre-operative admission for surgery
reported by the EIS in the emergency room record within
48 h before the onset of symptoms.
AIDS/HIV
the presence of an HIV positive or AIDS diagnosis (ICD-9-
CM codes 042–043; ICD-9 279.1), in any hospitalisation
before or after the onset of meningitis in the HIS 1996–
2005.
Community acquired
incident episodes of meningitis not classified as probable
hospital infection or in AIDS/HIV.
It is important to note that probable hospital infection
and AIDS/HIV are not mutually exclusive groups.
Aetiology
If different data sources reported different specified aetio-
logical agents, the laboratory data was considered correct;
when the laboratory record was not available, we checked
the clinical records.
We also calculated the proportion of meningitis cases
caused by vaccine-targeted bacteria: Haemophilus influen-
zae  b, Menigococcus C and the 7 Penumococcus sero-
groups included in the conjugated vaccine in 0–4 year old
children, and the 23 included in the polysaccharide vac-
cine for 5+ year olds. Furthermore, we also calculated the
proportion of vaccine-preventable meningitis in the target
ages: for Haemophilus iinfluenzae b, Pneumococcus (7
groups) and Meningococcus C 0–2 year old children and
65+ for Pneumoccoccus (23 groups). We decided to
include only community-acquired infections in the vac-
cine-preventable cases. This choice is based on the
assumption that most hospital infections, as well as the
infections in AIDS/HIV, are due to host factors; and in
these cases, the efficacy of vaccination is questionable.
This hypothesis also provides a conservative estimate of
the vaccine-preventable proportion of meningitis cases.
Capture-recapture method
Capture-recapture methods are widely used in epidemiol-
ogy to estimate the size of a population from a multiple-
record system [14]. The data set is the contingency table
obtained by the cross classification of the observed counts
according to whether or not they have been captured by
each of the lists. The unknown parameter then is the
number of individuals not captured by any of the lists,
which can be estimated under reasonable assumptions on
how the lists interact. When available, covariates are used
to form strata of individuals such that the inclusion prob-
ability in each list can be assumed homogeneous. Here weBMC Infectious Diseases 2009, 9:13 http://www.biomedcentral.com/1471-2334/9/13
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used two different sets of models: the first set of models
are based on the assumption that the counts of the contin-
gency table follow a Poisson distribution [15] and belong
to the class of log-linear models. To avoid sparse contin-
gency tables, the covariates were considered one at the
time. The limitation of this approach lies in the fact that
any possible confounding or interactions between differ-
ent covariates cannot be assessed. Confidence intervals for
the undercounts are derived from the property that they
follow an asymptotic Gaussian distribution [16]. The sec-
ond set of models assumes the existence of two latent
classes and models the effect of covariates on the odds of
belonging to one instead of the other and on the proba-
bility of appearing in each latent class conditionally on
the covariate [17].
Ethics
The present study did not require approval from an Ethics
Committee. The Agency for Public Health of the Lazio
Region is the governmental agency responsible for the col-
lection of infectious disease notifications, hospital dis-
charge records and laboratory surveillance.
The management of these data for public health purposes
does not require a patient's informed consent nor does it
require any authorization regarding privacy laws.
Results
Incidence
944 cases of meningitis were reported by at least one
source in the five years of the study period, in 934 individ-
uals (10 people had two independent episodes (table 1)).
For 43 other people with two reported episodes, checking
the medical records excluded the occurrence of two differ-
ent episodes of meningitis; consequently the second epi-
sode was not considered. The resulting incidence was
3.67/100,000/y in the general population, with a U-
shaped curve (table 2): a peak during the first year of life
(48.60/100,000/y) and in children aged 1 to 4 years
(11.29/100000/y) (table 3), and a second peak in adults
(4.26/100,000/y in the >64 year olds). Males had a higher
incidence than females (4.27/100,000/y vs 3.12/
100,000).
We classified 74 cases as suspected hospital acquired
infection (table 1): 45 had been hospitalised in the 10
days before the onset of symptoms, 34 were given a diag-
nosis of trauma in the emergency room or during the
admission. Twenty-six cases were of meningitis in HIV/
AIDS, three of these were also hospital-acquired.
Among the 845 community acquired meningitis cases,
695 had an identified aetiology (82.2%); the most com-
mon aetiological agent was Pneumococcus (24.6%), the
second was Meningococcus (18.0%). The hospital-
acquired infections did not show any predominant aetio-
logical bacteria: 40% of the infections were evenly distrib-
uted among Streptococcus spp., Pneumococcus, Stafilococcus
spp. Sixty-two percent of HIV/AIDS meningitis was tuber-
culosis (table 1).
The percentage of unidentified aetiology was 17.1%, the
"other not specified bacteria" (ICD-9-CM code 320.7
without the specific code in primary or secondary diagno-
sis and codes 320.81–320.89) accounted for 12.9%.
Time trends and geographical patterns
The absolute number of meningitis cases showed an
increasing trend from 175 to 224 (figure 1a). The increase
in incidence is less evident due to a larger denominator in
2005 (from 5.1 to 5.3 million): 3.4/100.000 in 2001 to
4.3/100.000 in 2005 (figure 1b). The increase in the abso-
lute number is stronger for cases in foreigners: from 17 to
38.
Table 1: Number of meningitis cases by aetiology and origin of the infection, 2001–2005, Lazio, Italy.
Community acquired Hospital infection HIV-related
Aetiological agent Total n % n % n %
Pneumococcus 221 208 24,6 12 16,2 2 7,7
Meningococcus 161 152 18,0 6 8,1 3 11,5
Tuberculosis 82 66 7,8 16 61,5
Streptococcus spp.* 62 51 6,0 11 14,9
Staphylococcus spp. 59 48 5,7 10 13,5 1 3,8
Haemophilus 46 43 5,1 3 4,0
Listeria 28 25 3,0 2 2,7 1 3,8
Salmonella 2 2 0,2
Other bacteria specified 39 33 3,9 5 6,8 1 3,8
Other bacteria NOS 83 67 7,9 14 18,9 2 7,7
Unknown 161 150 17,8 11 14,9
Total 944 845 100,0 74 100,0 26 100,0
* except Streptococcus pneumoniaeBMC Infectious Diseases 2009, 9:13 http://www.biomedcentral.com/1471-2334/9/13
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The incidence of meningitis due to H. influenzae b was the
only aetiology that decreased, from 3.49/100,000 to 2.03/
100,000 in the 0–4 age bracket.
Figure 2 shows the seasonality of community acquired
infections. In particular, pneumococcal disease and the
others, including unknown aetiology, had a winter peak,
while meningococcal disease showed a spring peak.
We observed a statistically significant geographical pat-
tern for community-acquired infections with higher inci-
dence in the city of Rome (standardised incidence rate
114, 95%CI 104–125) and in the suburbs (standardised
incidence rate 108, 95%CI 94–124) a lower incidence in
rural areas (standardised incidence rate 65, 95%CI 56–
76). While there was no discernible geographical trend in
hospital infections, 19 out of 26 cases (73%) of AIDS
meningitis were residents of Rome.
Distribution by type of the preventable aetiologies from 
LIS (table 4)
Haemophilus influenzae was typed in only 5 cases, all of
them were serogroup b. All types of pneumococcal men-
ingitis identified, out of 61 cases, are included in the 23-
valent polysaccharide vaccine, while only 70.5% are
included in the heptavalent conjugate, in the hypothesis
of total cross protection for the serogroups 6, 9, 18, 19 and
23. Out of the 45 Neisseria meningitis typed, 19 were sero-
group C and one was W-135, both of which are included
in the tetra-valent conjugate vaccine. The remaining 25
were serogroup B. The percentage of meningitis types tar-
geted by the vaccine, not considering age, was 31% of the
whole burden with a known aetiological agent.
None of the 28 Streptococcus spp. that caused meningitis in
the first three months of life were typed.
Table 2: Cases of bacterial meningitis, distribution by age and aetiology, 2001–2005, Lazio, Italy.
0–4 5–9 10–14 15–24 25–64 >64 m.i. Total
Population on 1/1/2003 230140 233211 250767 540633 2942446 948608 5145805
Pneumococcus 42 3 3 4 99 70 221
M e n i n g o c o c c u s 5 51 21 12 1 5 6 5 1 1 6 1
Tuberculosis 6 1 4 53 18 82
Streptococcus spp.* 29 1 1 2 17 12 62
Stafilococcus spp. 11 4 4 2 26 11 1 59
Haemophilus 25 1 4 6 10 46
Listeria 1 3 14 10 28
Salmonella 1 1 2
Other bacteria specified 11 3 12 13 39
Other bacteria NOS 13 5 5 10 32 18 83
Unknown 25 18 8 16 60 34 161
Total 219 44 33 69 375 202 2 944
* except Streptococcus pneumoniae
Table 3: Age 0–4 years: quarterly distribution of bacterial meningitis cases by aetiology, 2001–2005, Lazio, Italy.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 m.i Total
Meningococcus 3 9 12 4 5 5 3 1 1 1 3 3 4 1 55
P n e u m o c o c c u s 175 3 133 4 4 12314 4 2
Streptococcus spp.* 28 1 29
H a e m o p h i l u s 264 1 332 2 2 2 5
Stafilococcus spp. 2 1 1 1 2 1 2 1 11
Tuberculosis 1 1 1 1 1 1 6
Listeria 1 1
Salmonella 1 1
Other bacteria specified 8 1 1 1 11
Other bacteria NOS 3 1 2 1 1 5 13
U n k n o w n 423 1 1 11 22251 2 5
T o t a l 5 2 2 7 3 0 8 1 1 1 2 1 0 9 5 433698 2 03 2 1 9
* except Streptococcus pneumoniaeBMC Infectious Diseases 2009, 9:13 http://www.biomedcentral.com/1471-2334/9/13
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Fatality rate
Only two of the four sources collected information about
the death of patient: the HIS, which records in-hospital
mortality, and the NDS, which records short-term mortal-
ity. We calculated the case fatality rate for the cases
reported these two sources. The overall case fatality rate
was 13%, the highest was from tuberculosis and other
specified bacteria (both with 21%). None of the single
aetiologies differed from the mean after adjusting for age;
only the unknown aetiology was significantly less fatal
than the mean (figure 3a). Hospital infections had a
slightly higher fatality rate than community-acquired
(15.7% vs. 12.1%), while AIDS/HIV meningitis had a
fatality rate of 30.7%.
The fatality rate by age has a J-shaped curve (figure 3b):
7% (9/116) in 0–12 month olds, 6% in 1–4 year olds (6/
103), 2% in 5–9 (1/44), 0% in 10–14 (0/33), 3% in 15–
24 (2/69), 14% in 25–64 (54/375) and 24% in 65+ (49/
202). The case fatality rate was higher for females (14.6%
vs 11.1%); the difference is not statistically significant and
decreases when adjusted for age.
Capture re-capture
Figure 4 shows the relative contribution of the four
sources: the HIS and the NDS identified the most cases
(826 and 644 respectively), while the LIS and the HSS
identified 178 and 355 cases respectively, of which only
16 were not reported by the other sources.
The latent classes model estimated 17.2% underreporting
(some 196 undetected cases 95%CI 176–219). The fol-
lowing covariates reduced the probability of being
reported to one of the lists: the presence of AIDS/HIV;
probable hospital infections; being a foreigner; and being
a foreigner. The underreporting is near zero for meningitis
caused by the three bacteria under laboratory surveillance
(2.6%) (table 5). These influences were all confirmed in
the log linear model.
Discussion
Limits and methodological remarks
The surveillance system presented here has evolved from
the three-source surveillance system presented by Faustini
et al in 2001 [18]. We have added the laboratory surveil-
lance, which does not substantially change the sensitivity
of the system given the few cases reported by this source
alone, but it improved the accuracy of the aetiological
information. The previous work on integrated surveil-
lance calculated the specificity of the case definition
checking all the case's clinical files; they found that 20%
of meningitis reported by the surveillance system was not
confirmed by a panel of experts. A similar study was per-
formed in another Italian region with similar results [19].
The surveillance does not include death certificates among
the sources, because the mortality information system is
not timely and the final version of the archive is available
only after a couple of years. Consequently, we cannot
ascertain 30-day mortality. A recent study compared the
Bacterial meningitis in Lazio, Italy, 2001–2005 Figure 1
Bacterial meningitis in Lazio, Italy, 2001–2005. 
Number of cases by place of birth and incidence by aetiologi-
cal agent. 2a, the actual denominator of foreign-born people 
is not available, so only absolute numbers can be compared; 
2b, in the incidence only residents of Lazio are included, 
independent of citizenship.
0
50
100
150
200
250
2001 2002 2003 2004 2005
n
u
m
b
e
r
 
o
f
 
c
a
s
e
s
foreign-born Italian Total
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
2001 2002 2003 2004 2005
i
n
c
i
d
e
n
c
e
/
1
0
0
,
0
0
0
/
y
Meningococcus H. influenzae b Pneumococcus all
a.
b.
Bacterial meningitis in Lazio, Italy, 2001–2005 Figure 2
Bacterial meningitis in Lazio, Italy, 2001–2005. Sea-
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fatality rate of meningitis in Lazio calculated using the
information reported by the hospital and the mandatory
notification system with the gold standard of linkage with
the mortality registry [20], and the results were very simi-
lar.
The method we used to distinguish community-acquired
meningitis and hospital infections has not been validated.
We adapted it from the inclusion criteria for community-
acquired pneumonia used by Romano et al in construct-
ing a cohort to evaluate outcomes of patients hospitalised
for pneumonia in California [21].
The criteria and the information sources to classify men-
ingitis infection in AIDS/HIV have been used and vali-
dated before [12].
Incidence and trends
The incidence of pneumococcal meningitis in our region
is low, but it is comparable to the values found in other
European Countries [22] and in another Italian region for
children [23]. However, the meningococcal meningitis
incidence observed in our region is at the higher end of
the range observed in Europe [24-26].
Children experience the highest incidence. There are sev-
eral aetiologies and the most common, i.e. Pneumococ-
cus, is responsible for only 25%. The percentage of
unknown aetiology is comparable to that found with
other surveillance systems based on clinical reports and
laboratory isolates, but the percentage of "other bacteria"
for which we could not identify the aetiology is a concern;
these cases are generally detected only by the hospital
information system.
There is an increasing trend in the absolute numbers.
There were no changes in the surveillance systems in the
study period and we tried to exclude any bias due to a
reduction of underreporting. The increasing number of
meningitis cases is due predominantly to cases that
occurred in immigrants. There are three possible causes
for this specific increase: a larger denominator, a specific
reduction of underreporting in this population, and/or an
increased incidence in this group. Despite the fact that
there is a substantial lack of knowledge about the foreign
population living in our region, over the last three years
the number of resident immigrants increased by 14%
[27]. Some of the foreign population in recent years have
been integrated into Italian society, a process that proba-
bly indicates easier access to health services and conse-
quently a higher probability of reporting infectious
diseases. Finally, while it cannot be excluded, there is no
evidence that meningitis risk has increased in the foreign
population in the last five years.
Table 4: Meningitis aetiological agent serotypes identified by the Laboratory Information System, 2001–2005, Lazio, Italy.
Pneumococcus serogroup n Meningococcus serogroup n Haemophilus serotype n
14 9 B 25 B 5
19 9 C 19 not available 8
23 8 W135 1 Total 13
6 8 not available 14
14 T o t a l 5 9
18 4
43
73
92
15 2
22 2
31
51
81
10 1
11 1
12 1
33 1
not available 30
Total 91BMC Infectious Diseases 2009, 9:13 http://www.biomedcentral.com/1471-2334/9/13
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Very few studies have tried to distinguish the burden of
community-acquired meningitis and hospital-acquired
meningitis, consequently we have little data to use for
comparison [28-31].
Capture-recapture models estimate that about 40 cases
per year are not reported to any source. Underreporting to
the mandatory notification system is estimated to be 50%.
The hospital information system is the source that
increases the sensitivity of the surveillance. Interestingly,
meningitis occurring in foreign citizens is reported less
often, reflecting the well-known barriers to health service
access experienced by immigrants [32,33].
Other categories of meningitis affected by underreporting
are in AIDS patients and the probable hospital infections.
The first are probably seen as complications of a disease
that has already been reported; while the second are prob-
ably affected by an opportunistic underreporting in an
effort by the hospital to avoid responsibility. Finally, the
absence of underreporting for the three bacteria under
specific laboratory surveillance is very encouraging, indi-
cating that the figures on which we are planning our vac-
cination policies are reliable.
The fatality rate in our setting is 13%, comparable to data
reported by other surveillance systems in industrialised
countries [26,34]. The rates do not differ by aetiology
except for the cases with unknown aetiology that have a
significantly lower case fatality rate. A previous validation
study found that these cases have a higher proportion of
unconfirmed cases [18].
The proportion of cases due to vaccine-targeted bacteria is
about 31%, but only one-half of these stuck subjects in
the target population of plausible vaccination campaigns,
i.e. Haemophilus influenzae b, Pneumococcus and Menin-
gococcus in young children or Pneumococcus over 65;
consequently, the overall effect of a vaccination campaign
would be seen only after several years. Meningitis by Hae-
mophilus influenzae b was the only type which decreased in
number and incidence, this is probably the effect of
increased immunisation coverage, from 30% in 2001 to
89% in 2005. A similar association has been observed in
our and other countries [35-38]. More than half of the
cases that occurred in the first three months of life are due
to  Streptococcus spp, excluding Streptococcus pneumoniae.
These kinds of infections are mostly due to mother-child
transmission during delivery and are highly preventable
with maternal screening and prophylactic antibiotics [39].
Bacterial meningitis Case Fatality Rate by aetiological agent  and age Figure 3
Bacterial meningitis Case Fatality Rate by aetiologi-
cal agent and age. The top of the figure reports the row 
CFR (%) for each aetiological agent, the expected number of 
deaths according to age-specific death rates for each age 
bracket, the standardised fatality ratio (i.e. observed deaths/
expected deaths*100) and the relative confidence intervals. 
The graph reports age-specific fatality rates for all meningitis. 
The category "other" includes unknown aetiology. 2001–
2005, Lazio, Italy.
Aetiology n deaths
Row 
CFR%
expected 
deaths
standardi-
sed case 
fatality 
rate
Pneumococcus 221 40 18 34.2 117.0 84 - 159
Meningococcus 161 15 9 13.9 107.9 60 - 178
Tuberculosis 82 17 21 12.5 136.2 79 - 218
Streptococcus spp * 62 7 11 7.7 91.0 37 - 188
Staphylococcus spp  59 9 15 7.3 124.0 57 - 235
Haemophilus 46 6 13 5.1 116.8 43 - 254
Listeria 28 2 7 4.6 43.4 5 - 157
Salmonella spp  2 0 0 0.3 0.0 0 - 1152
Unknown 161 9 6 19.4 46.4 21 - 88
Other bacteria specified  39 8 21 5.8 138.3 60 - 273
Other bacteria NOS 83 8 10 10.3 78.0 34 - 154
Total 944 121 13 121.0
* except Streptococcus pneumoniae
95% Confidence 
interval
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Cases of bacterial meningitis in Lazio, Italy, 2001–2005 Figure 4
Cases of bacterial meningitis in Lazio, Italy, 2001–
2005. Results of the record linkage of the four data sources: 
hospital surveillance of bacterial meningitis (HSS), laboratory 
information system (LIS), the mandatory infectious diseases 
notifications (NDS), and hospital information system (HIS). 
The largest set includes the undetected cases as estimated by 
the capture-recapture model.
NDS
HIS
HSS
HSS = 355
NDS = 644 HIS = 826
LIS = 178
5
LIS
10
259
74
106
197
38
20
1
201
1
10
10 5
7
• All sources: 944 cases
Estimated
Not reported =
196 (95% CI 170-219)BMC Infectious Diseases 2009, 9:13 http://www.biomedcentral.com/1471-2334/9/13
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Conclusion
The results of this surveillance system were utilised to
define public health control interventions against bacte-
rial meningitis in Lazio and provide baseline data to
assess the impact of these measures in the future.
The surveillance system allowed us to monitor the impact
of the vaccination campaign against Haemophylus influen-
zae type b. Even though Pneumococcus is the most com-
mon pathogen, fewer than 5 cases per year would be
prevented by a mass vaccination of infants with the hep-
tavalent conjugate vaccine. A prevention intervention to
control streptococcus infections in the first three months
of life would have a greater impact on reducing the
number of meningitis cases.
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